• Join
  • Login
  • Contact

Search abstracts

Aptamer anchored nano-architectures for treatment of drug resistant cancer

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: KESHARWANI, Prashant (Central Drug Research Institute, Lucknow, Pharmaceutics and Pharmacokinetics)
  • Co-author(s): Prashant Kesharwani
  • Abstract:


    Despite numerous advances in surgical treatment, chemotherapy and molecular 
    targeted agents for NSCLC, metastasis and multidrug resistance are still major causes for 
    failures in treating lung cancer patients
    . Thus, it is highly desirable to develop new therapeutic 
    approaches beyond conventional treatment for NSCLC



  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses